Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ming-Xing Miao"'
Autor:
Zhi-hui Zhang, Liu-liu Sun, Bu-qing Fu, Jie Deng, Cheng-lin Jia, Ming-xing Miao, Feng Yang, Yong-bing Cao, Tian-hua Yan
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
Cryptococcus neoformans is at the top of the list of “most wanted” human pathogens. Only three classes of antifungal drugs are available for the treatment of cryptococcosis. Studies on antifungal resistance mechanisms are limited to the investiga
Externí odkaz:
https://doaj.org/article/679e505e58fe44c4af9952558d8fef07
Autor:
Shu‐Chang Ma, Jia‐Qi Zhang, Tian‐Hua Yan, Ming‐Xing Miao, Ye‐Min Cao, Yong‐Bing Cao, Li‐Chao Zhang, Ling Li
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11073-11096 (2023)
Abstract Colorectal cancer (CRC) is a common gastrointestinal malignancy with high morbidity and fatality. Chemotherapy, as traditional therapy for CRC, has exerted well antitumor effect and greatly improved the survival of CRC patients. Nevertheless
Externí odkaz:
https://doaj.org/article/6c78f327e58c46d6a5153cbb473f0de7
Autor:
Hao Li, Ming-xing Miao, Cheng-lin Jia, Yong-bing Cao, Tian-hua Yan, Yuan-ying Jiang, Feng Yang
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Candida albicans is a prevalent, opportunistic human fungal pathogen. It usually dwells in the human body as a commensal, however, once in its pathogenic state, it causes diseases ranging from debilitating superficial to life-threatening systemic inf
Externí odkaz:
https://doaj.org/article/4dad46fe52d04300a65d86f1473ea432
Publikováno v:
Molecules, Vol 18, Iss 8, Pp 8976-8993 (2013)
The potent anti-hyperuricemia activities of Fructus Gardenia Extract (FGE) have been well reported. The aim of this study was to evaluate the uricosuric and nephro-protective effects of FGE and explore its possible mechanisms of action in oxonate-ind
Externí odkaz:
https://doaj.org/article/3ea633f905f44f4c8417a65f294d0555
Autor:
Hao, Li, Ming-Xing, Miao, Cheng-Lin, Jia, Yong-Bing, Cao, Tian-Hua, Yan, Yuan-Ying, Jiang, Feng, Yang
Publikováno v:
Frontiers in microbiology. 13
Autor:
Mei Hu, Kai Long Zhong, Hao Hong, Hao Wang, Ming Xing Miao, Jian Min Liao, Su Su Tang, Yan Long, Hong Bing Sun, Fang Chen
Publikováno v:
British Journal of Pharmacology. 173:372-385
Background and purpose There is emerging evidence suggesting that abnormal transport of amyloid-β (Aβ) across the blood-brain barrier (BBB) is involved in diabetes-associated cognitive decline. We investigated whether PPARγ agonists restore Aβ tr
Autor:
Cai-Rong, Zhang, Ji-Li, Deng, Wei-Na, Zhu, Ming-Xing, Miao, Wei-Wei, Shen, Sheng-Jun, Cao, Yong, Tang
Publikováno v:
Zhen ci yan jiu = Acupuncture research. 43(2)
To study the protective effect of moxibustion for tripterygium-induced premature ovarian failure (POF) and its underlying mechanisms in rats.Forty-five female SD rats were randomly divided into normal control, POF model and moxibustion groups (After
Autor:
Hao Hong, Zhen Lin Mei, Ning Li, Ming Xing Miao, Hao Wang, Yan Long, Mei Hu, Tianhua Yan, Kai Long Zhong
Publikováno v:
Pharmacology Biochemistry and Behavior. 124:373-379
Amyloid-β peptide (Aβ) is thought to be associated with the progressive neuronal death observed in Alzheimer's disease (AD). However, effective neuroprotective approaches against Aβ neurotoxicity are unavailable. Here, we investigated possible pre
Autor:
Xiao-Bing Wang, Ling-yi Kong, Jin’e Lai, Mei Hu, Hao Wang, Hao Hong, Yan Long, Jia-chang Li, Meng Hu, Ming-xing Miao
Publikováno v:
Neuropharmacology. 79:707-714
Montelukast, known as a cysteinyl leukotriene receptor 1 (CysLT1R) antagonist, is currently used for treatment of inflammatory diseases such as asthma. Here, we investigated effects of montelukast on neuroinflammatory, apoptotic responses, and memory
Autor:
Chao Wang, Ming Xing Miao, Hao Hong, Guang Jun Liu, Zhen Lin Mei, Yan Long, Guan Tao Du, Meng Hu, Jia Chang Li, Mei Hu
Publikováno v:
Journal of Pharmacological Sciences, Vol 124, Iss 4, Pp 418-426 (2014)
Telmisartan, an angiotensin II type 1–receptor blocker (ARBs), has been reported to exert beneficial effects on the central nervous system (CNS). However, the effect of telmisartan on cognitive impairment associated with type 1 diabetes is not well